RxDB
ICD-10-PCS Codes Browse (Tables)

ICD-10 PCS – Browse (Tables)

Code Title
– Top Categories
3 Administration
3E Physiological Systems and Anatomical Regions
3E0 Introduction Administration, Physiological Systems and Anatomical Regions, Introduction
3E05 Peripheral Artery
3E050 Open
3E0500 Antineoplastic
3E05002 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
3E05003 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach
3E05005 Other Antineoplastic Introduction of Other Antineoplastic into Peripheral Artery, Open Approach
3E0500M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
3E0500P Clofarabine Introduction of Clofarabine into Peripheral Artery, Open Approach
3E0501 Thrombolytic
3E05016 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open
3E05017 Other Thrombolytic Introduction of Other Thrombolytic into Peripheral Artery, Open Approach
3E0502 Anti-infective
3E05028 Oxazolidinones Introduction of Oxazolidinones into Peripheral Artery, Open Approach
3E05029 Other Anti-infective Introduction of Other Anti-infective into Peripheral Artery, Open Approach
3E0503 Anti-inflammatory
3E0503Z No Qualifier Introduction of Anti-inflammatory into Peripheral Artery, Open Approach
3E0504 Serum, Toxoid and Vaccine
3E0504Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach
3E0506 Nutritional Substance
3E0506Z No Qualifier Introduction of Nutritional Substance into Peripheral Artery, Open Approach
3E0507 Electrolytic and Water Balance Substance
3E0507Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach
3E050F Intracirculatory Anesthetic
3E050FZ No Qualifier Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach
3E050G Other Therapeutic Substance
3E050GC Other Substance Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach
3E050GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach
3E050H Radioactive Substance
3E050HZ No Qualifier Introduction of Radioactive Substance into Peripheral Artery, Open Approach
3E050K Other Diagnostic Substance
3E050KZ No Qualifier Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach
3E050N Analgesics, Hypnotics, Sedatives
3E050NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach
3E050P Platelet Inhibitor
3E050PZ No Qualifier Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach
3E050R Antiarrhythmic
3E050RZ No Qualifier Introduction of Antiarrhythmic into Peripheral Artery, Open Approach
3E050T Destructive Agent
3E050TZ No Qualifier Introduction of Destructive Agent into Peripheral Artery, Open Approach
3E050V Hormone
3E050VG Insulin Introduction of Insulin into Peripheral Artery, Open Approach
3E050VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach
3E050VJ Other Hormone Introduction of Other Hormone into Peripheral Artery, Open Approach
3E050W Immunotherapeutic
3E050WK Immunostimulator Introduction of Immunostimulator into Peripheral Artery, Open
3E050WL Immunosuppressive Introduction of Immunosuppressive into Peripheral Artery, Open
3E050X Vasopressor
3E050XZ No Qualifier Introduction of Vasopressor into Peripheral Artery, Open Approach
3E053 Percutaneous
3E0530 Antineoplastic
3E05302 High-dose Interleukin-2 Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
3E05303 Low-dose Interleukin-2 Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
3E05305 Other Antineoplastic Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach
3E0530M Monoclonal Antibody Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
3E0530P Clofarabine Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach
3E0531 Thrombolytic
3E05316 Recombinant Human-activated Protein C Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous
3E05317 Other Thrombolytic Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach
3E0532 Anti-infective
3E05328 Oxazolidinones Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach
3E05329 Other Anti-infective Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach
3E0533 Anti-inflammatory
3E0533Z No Qualifier Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach
3E0534 Serum, Toxoid and Vaccine
3E0534Z No Qualifier Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach
3E0536 Nutritional Substance
3E0536Z No Qualifier Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach
3E0537 Electrolytic and Water Balance Substance
3E0537Z No Qualifier Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach
3E053F Intracirculatory Anesthetic
3E053FZ No Qualifier Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach
3E053G Other Therapeutic Substance
3E053GC Other Substance Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach
3E053GN Blood Brain Barrier Disruption Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach
3E053H Radioactive Substance
3E053HZ No Qualifier Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach
3E053K Other Diagnostic Substance
3E053KZ No Qualifier Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach
3E053N Analgesics, Hypnotics, Sedatives
3E053NZ No Qualifier Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach
3E053P Platelet Inhibitor
3E053PZ No Qualifier Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach
3E053R Antiarrhythmic
3E053RZ No Qualifier Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach
3E053T Destructive Agent
3E053TZ No Qualifier Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach
3E053V Hormone
3E053VG Insulin Introduction of Insulin into Peripheral Artery, Percutaneous Approach
3E053VH Human B-type Natriuretic Peptide Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach
3E053VJ Other Hormone Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach
3E053W Immunotherapeutic
3E053WK Immunostimulator Introduction of Immunostimulator into Peripheral Artery, Percutaneous
3E053WL Immunosuppressive Introduction of Immunosuppressive into Peripheral Artery, Percutaneous
3E053X Vasopressor
3E053XZ No Qualifier Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach